AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23740477
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of both (COM)
Trial: 21123766
Drug: Atorvastatin, 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin, 40 mg/day
Trial: 19652945
Drug: Low-protein diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-protein diet (0.8 g kg(‐1) day(‐1))
Trial: 19652945
Drug: Normal-protein diet
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal-protein diet (1.2 g kg(‐1) day(‐1))
Trial: 17960012
Drug: TPF (docetaxel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TPF (docetaxel and cisplatin on day 1; fluorouracil by continuous infusion, days 1 to 5)
Trial: 8373716
Drug: Naproxen 250
RxNorm normalized name: naproxen 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen 250 mg twice daily for 3 days
Trial: 8373716
Drug: Indomethacin 25
RxNorm normalized name: indomethacin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 25 mg twice daily
Trial: 28033693
Drug: Morphine suppository
RxNorm normalized name: morphine Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine suppository (10 mg)
Trial: 10669898
Drug: Diclofenac suppository
RxNorm normalized name: diclofenac Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac suppository (100 mg)
Trial: 18712029
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate lotion 0.05%
Trial: 18712029
Drug: OTC anti‐itch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OTC anti‐itch preparation containing benzyl alcohol
Trial: 14513648
Drug: Triptorelin 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triptorelin 0.1 mg subcutaneously daily for 7 days starting on day 21 of menstrual cycle
Trial: 14513648
Drug: Buserelin intranasal
RxNorm normalized name: buserelin
DrugBank: Buserelin (DB06719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buserelin intranasal spray (long protocol)
Trial: 10371363
Drug: Nurse-community health
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurse-community health worker team in combination with usual medical care (SI)
Trial: 6816316
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of endocrine and chemical therapies
Trial: 28686808
Drug: CenteringPregnancy Oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CenteringPregnancy Oral Health Promotion intervention (two 15-minute skills-based educational modules)
Trial: 21130446
Drug: 400‐μg sublingual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400‐μg sublingual misoprostol plus routine uterotonics
Trial: 21130446
Drug: 400‐μg sublingual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400‐μg sublingual misoprostol
Trial: 9834799
Drug: CC (clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC (clinical criteria)
Trial: 7857516
Drug: 3 x
RxNorm normalized name: Xenon (133 xe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 x 300 mg hypericum extract
Trial: 799996
Drug: Butorphanol tartrate
RxNorm normalized name: Butorphanol Tartrate
DrugBank: Butorphanol (DB00611)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Butorphanol tartrate (1, 2, and 4 mg)
Trial: 799996
Drug: Pentazocine lactate
RxNorm normalized name: Pentazocine Lactate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentazocine lactate (30 and 60 mg)
Trial: 25964369
Drug: Mandatory daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mandatory daily hand washing before lunch
Trial: 22282730
Drug: Immediate implant
RxNorm normalized name: IR-3535
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate implant placement (54 patients)
Trial: 8056998
Drug: lorazepam 0.5
RxNorm normalized name: lorazepam 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lorazepam 0.5 mg
Trial: 18668226
Drug: lorazepam 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lorazepam 1.0 mg
Trial: 14581110
Drug: Remifentanil infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil infusion for 90 minutes
Trial: 14581110
Drug: Co-administration of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-administration of S-ketamine
Trial: 4051686
Drug: Paraprofessional drug
RxNorm normalized name: Clearskin Professional Daily Correcting
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paraprofessional drug counseling alone
Trial: 27981431
Drug: enzalutamide 160
RxNorm normalized name: Enzalutamide
DrugBank: Enzalutamide (DB08899)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: enzalutamide 160 mg/day
Trial: 25720808
Drug: Marbofloxacin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marbofloxacin (2 mg/kg, IV, once; MRFX group)
Trial: 25720808
Drug: Enrofloxacin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enrofloxacin (5 mg/kg, IV, once; ERFX group)
Trial: 25720808
Drug: Control (saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (saline solution 0.9% NaCl, 10 ml, IV, once)
Trial: 25720808
Drug: Marbofloxacin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marbofloxacin (2 mg/kg, IV, once; MRFX group) and Enrofloxacin (5 mg/kg, IV, once; ERFX group)
Trial: 19873912
Drug: Linggui Bafa
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Linggui Bafa acupuncture treatment
Trial: 19873912
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no acupuncture or oral medication)
Trial: 15304576
Drug: Serum fibrinogen
RxNorm normalized name: fibrinogen
DrugBank: Fibrinogen human (DB09222)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum fibrinogen levels >523 mg/dL
Trial: 9762782
Drug: Formoterol 72
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol 72 microg (4+4+4 doses)
Trial: 9762782
Drug: Terbutaline 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline 6 mg (4+4+4 doses)
Trial: 9762782
Drug: Formoterol 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol 120 microg (8+6+6 doses)
Trial: 9762782
Drug: Terbutaline 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline 10 mg (8+6+6 doses)
Trial: 2894490
Drug: Intravenous APSAC
RxNorm normalized name: APSAC
DrugBank: Anistreplase (DB00029)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous APSAC (30 unit dose)
Trial: 30068306
Drug: Gentamicin-collagen sponge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin-collagen sponge with systemic antibiotic therapy
Trial: 30068306
Drug: Systemic antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic antibiotics alone (Control)
Trial: 26825817
Drug: Intravenous fluids
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous fluids (IVF)
Trial: 26825817
Drug: No intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No intravenous fluids (IVF)
Trial: 19925497
Drug: Immediate-release omeprazole
RxNorm normalized name: aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediate-release omeprazole 40 mg suspension o.m. for 7 days
Trial: 19925497
Drug: Delayed-release omeprazole
RxNorm normalized name: omeprazole Delayed Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed-release omeprazole 40 mg capsule o.m. for 7 days
Trial: 17917501
Drug: Aliskiren 150
RxNorm normalized name: aliskiren 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren 150 mg plus amlodipine 5 mg
Trial: 8290195
Drug: Piperacillin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piperacillin (3 g every 6 hours) and Tazobactam (375 mg every 6 hours)
Trial: 8290195
Drug: Clindamycin (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin (900 mg every 8 hours) and Gentamicin (2.5-5.0 mg/kg/day in three divided doses)
Trial: 3187936
Drug: 135 g
RxNorm normalized name: SODIUM CHLORIDE 0.135 g in 15 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 135 g of canned mackerel paste (experimental group)
Trial: 5763957
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of phenylpropanolamine taken orally
Trial: 5763957
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of phenylpropanolamine taken orally
Trial: 5763957
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of phenylpropanolamine taken orally (in a subject taking tranylcypromine)
Trial: 5763957
Drug: Proprietary cough
RxNorm normalized name: Pediaclear Cough
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proprietary cough linctus containing 50 mg of phenylpropanolamine (in a subject taking tranylcypromine)
Trial: 5763957
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of phentolamine
Trial: 30107789
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Motion Simulation and Whole Body Vibration (MSim + WBV)
Trial: 26867199
Drug: Gluten intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gluten intake (5.6 g/day) for 7 days after a 3-week gluten-free diet (GFD)
Trial: 25711318
Drug: Immediate treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate treatment at a CD4 cell count of 500 cells/μL or higher
Trial: 25711318
Drug: Deferring treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deferring treatment until the CD4 cell count decreases to 350 cells/μL or until AIDS develops
Trial: 23809257
Drug: Hybrid model
RxNorm normalized name: Amaranthus hybridus pollen
DrugBank: Amaranthus hybridus pollen (DB15503)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hybrid model of combined modified constraint induced movement therapy (mCIMT) followed by intensive bimanual training (COMBiT)
Trial: 23809257
Drug: Distributed model
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Distributed model of standard occupational therapy and physiotherapy care (SC)
Trial: 17079587
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy (3 one-on-one sessions per week for 8 weeks, followed by a home program for another 6 weeks)
Trial: 15514272
Drug: 10 mg/d
RxNorm normalized name: Arixtra 10 mg/dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/d iron supplementation for 12 months
Trial: 9919895
Drug: Itraconazole 200
RxNorm normalized name: itraconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole 200 mg daily for 1 week
Trial: 2965462
Drug: 2 microgram
RxNorm normalized name: Paricalcitol 2 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 microgram doses of hepatitis B vaccine (HB-Vax) administered intradermally at months 0 and 1, followed by two booster injections at months 5 and 10
Trial: 2965462
Drug: 2 microgram
RxNorm normalized name: Paricalcitol 2 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 microgram doses of hepatitis B vaccine (HB-Vax) administered intradermally
Trial: 29249166
Drug: Rivaroxaban 2.5
RxNorm normalized name: rivaroxaban 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban 2.5 mg b.i.d.
Trial: 23666451
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of naloxone 0.1 mg, droperidol 2 mg, and dexamethasone 8 mg (Cm group)
Trial: 23666451
Drug: Naloxone 0.1
RxNorm normalized name: naloxone 0.18 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone 0.1 mg (Nx group)
Trial: 23666451
Drug: Dexamethasone 8
RxNorm normalized name: dexamethasone 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 8 mg (Dx group)
Trial: 23666451
Drug: Droperidol 1
RxNorm normalized name: droperidol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol 1 mg (Dr group)
Trial: 19468216
Drug: Factor Seven
RxNorm normalized name: factor VIIa Injection [Sevenfact]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Factor Seven for Acute Hemorrhagic Stroke (treatment group)
Trial: 16624768
Drug: Mechanical periodontal
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mechanical periodontal treatment combined with tetracycline
Trial: 16624768
Drug: Exclusive mechanical
RxNorm normalized name: PIPERONYL BUTOXIDE TECHNICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exclusive mechanical periodontal treatment
Trial: 15470169
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose sufentanil (0.025 microg x kg(‐1) for the first patient and 0.1 microg x kg(‐1) for the other two patients)
Trial: 15470169
Drug: Atropine 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine 0.6 mg i.v.
Trial: 7862546
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of relaxation and music
Trial: 8067145
Drug: Two tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two tablets containing 100,000 binding units (BU) of the toxoid and 2,500 units of O-antigen for children 11-14 years
Trial: 8067145
Drug: Four tablets
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four tablets containing 200,000 BU of the toxoid and 5,000 units of O-antigen for adolescents aged 15-17 years
Trial: 2099071
Drug: Oral cholera
RxNorm normalized name: VIBRIO CHOLERAE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cholera vaccine
Trial: 28351962
Drug: β-blocker-treated Gly49
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: β-blocker-treated Gly49 carriers
Trial: 28351962
Drug: Non-carriers and
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-carriers and non-β-blocker-treated individuals
Trial: 26755209
Drug: Clown therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clown therapy (interaction with clowns)
Trial: 25079090
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose nevirapine during first ANC appointment
Trial: 17564955
Drug: 20 U
RxNorm normalized name: vitamin E 20 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 U of oxytocin in 30 mL of saline
Trial: 17564955
Drug: 30 mL
RxNorm normalized name: Vial M/T 30 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mL of saline
Trial: 15097300
Drug: ART +
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ART + IL-2 (1 million IU subcutaneously once daily)
Trial: 9665682
Drug: Very low
RxNorm normalized name: Very low fat spread
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very low calorie diet with 3.0 g fat/d
Trial: 9665682
Drug: Very low
RxNorm normalized name: Very low fat spread
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very low calorie diet with 12.2 g fat/d
Trial: 10893703
Drug: Pethidine 0.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pethidine 0.7 mg/kg
Trial: 30395147
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as Usual (Control)
Trial: 19194119
Drug: Granisetron 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron 0.5 mg per oral (days 2 and 3)
Trial: 19194119
Drug: Placebo on
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo on day 2 and granisetron 0.5 mg on days 3 and 4
Trial: 29878583
Drug: BAY 1142524
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY 1142524 (1-200 mg single oral doses, 5-50 mg twice daily, 100 mg once daily for 5 days)
Trial: 29878583
Drug: BAY 1142524
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY 1142524 (5 mg dose)
Trial: 29878583
Drug: BAY 1142524
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY 1142524 (liquid service formulation or IR tablets)
Trial: 29878583
Drug: BAY 1142524
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY 1142524 (multiple dosing)
Trial: 16124370
Drug: Fenspiride (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenspiride (2 ml/kg/day in three divided doses)
Trial: 16124370
Drug: Amoxicillin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (80 mg/kg/day in three partite doses) + Oxymethazolin (0.05% nasal drops 3 x day)
Trial: 12160337
Drug: Muscle Learning
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Muscle Learning Therapy (MLT)
Trial: 10352334
Drug: Desferrioxamine (DFO)
RxNorm normalized name: DFO
DrugBank: Deferoxamine (DB00746)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desferrioxamine (DFO) 30-40 mg/kg by slow intravenous infusion
Trial: 31088195
Drug: Single‐ and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single‐ and multiple‐dose injectable Ginkgolide B (GB)
Trial: 31088195
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg once‐daily dosing of Ginkgolide B (GB)
Trial: 31088195
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg Ginkgolide B (GB)
Trial: 31088195
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg Ginkgolide B (GB)
Trial: 31088195
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg Ginkgolide B (GB)
Trial: 31088195
Drug: Repeated once‐daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated once‐daily dosing of Ginkgolide B (GB)
Trial: 31088195
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of Ginkgolide B (GB)
Trial: 25661338
Drug: Antimony treatment
RxNorm normalized name: antimony
DrugBank: Antimony (DB13110)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimony treatment
Trial: 23945574
Drug: Injectable penicillin‐gentamicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injectable penicillin‐gentamicin combination
Trial: 16782974
Drug: Melatonin 3
RxNorm normalized name: melatonin 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 3 mg and 6 mg (given 10 min before sedation)
Trial: 15255454
Drug: Multivitamin/mineral supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multivitamin/mineral supplementation (36 mg vitamin E, 150 mg vitamin C, 9 mg beta-carotene) for 6 months
Trial: 15255454
Drug: Placebo capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsule for 6 months
Trial: 11296164
Drug: Montelukast and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast and Salmeterol (after 2 weeks of treatment)
Trial: 9311490
Drug: Aerosolized lipid-extracted
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosolized lipid-extracted bovine surfactant (Alveofact) 120 mg
Trial: 2878745
Drug: Intranasal synthetic
RxNorm normalized name: Synthetic camphor
DrugBank: Synthetic camphor (DB14156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal synthetic LHRH
Trial: 28111428
Drug: Simvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (40 mg/day) plus Afatinib (40 mg/day)
Trial: 8884896
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin C 1 g daily
Trial: 1414398
Drug: s-adenosyl-l-methionine (SAMe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: s-adenosyl-l-methionine (SAMe)
Trial: 1414398
Drug: TSH response
RxNorm normalized name: Besponsa
DrugBank: Inotuzumab ozogamicin (DB05889)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: TSH response outside the normal range (7-25 uU/ml)
Trial: 1414398
Drug: absolute deviations
RxNorm normalized name: Honey Absolute
DrugBank: Honey (DB14242)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: absolute deviations from the mean TSH response (16 uU/ml)
Trial: 16569544
Drug: Clinic-only (CO)
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinic-only (CO) carvedilol titration
Trial: 11685160
Drug: Noetic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noetic therapy (stress relaxation, imagery, touch therapy, prayer)
Trial: 11685160
Drug: Noetic therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noetic therapies
Trial: 9450158
Drug: pivagabine (1800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pivagabine (1800 mg orally for 30 days)
Trial: 3376901
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (400 micrograms.kg‐1.d‐1 of intravenous Zn)
Trial: 24404797
Drug: Oral corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral corticosteroids (OC)
Trial: 22951317
Drug: Citicoline 1000mg
RxNorm normalized name: citicoline 1000 MG
DrugBank: Citicoline (DB12153)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citicoline 1000mg (test preparation)